Postradical prostatectomy prostate‐specific antigen outcomes after 6 versus 18 months of perioperative androgen‐deprivation therapy in men with localized, unfavorable intermediate‐risk or high‐risk prostate cancer: Results of part 2 of a randomized phase 2 trial

McKay, Rana R. ; Xie, Wanling ; Yang, Xiaoyu ; Acosta, Andres ; Rathkopf, Dana ; Laudone, Vincent P. ; Bubley, Glenn J. ; Einstein, David J. ; Chang, Peter ; Wagner, Andrew A. ; Kane, Christopher J. ; Preston, Mark A. ; Kilbridge, Kerry ; Chang, Steven L. ; Choudhury, Atish D. ; Pomerantz, Mark M. ; Trinh, Quoc‐Dien ; Kibel, Adam S. ; Taplin, Mary‐Ellen

Cancer, 2024-05, Vol.130 (9), p.1629-1641 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível